Alpha 2.0
Login Register
» Authors » B Holleczek

B Holleczek

Explore the profile of B Holleczek including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 456
Followers 0
Related Specialties
Oncology
Public Health
Psychiatry
Top 10 Co-Authors
H Brenner
A Katalinic
A Gondos
A Eberle
S Luttmann
K Emrich
L Jansen
K Kraywinkel
B Schottker
A Waldmann
Published In
Ann Oncol
Eur J Cancer
J Eur Acad Dermatol Venereol
Gesundheitswesen
Cancer Epidemiol
Affiliations
Soon will be listed here.
Recent Articles
1.
Proposal for a descriptive and differentiated presentation of the longitudinal impact of the new organized cancer screening guideline and HPV vaccination in Germany
Neis F, Holleczek B, Henes M, Juhasz-Boss I, Wallwiener D, Neis K
Arch Gynecol Obstet . 2022 Sep; 307(4):1125-1136. PMID: 36053348
Introduction: Since 01/01/2020, the cervical cancer screening in Germany has been carried out due to the organized early cancer diagnosis guideline (oKFE-RL). In 2007, HPV vaccination was initiated in Germany....
2.
Correction: Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years
Stocker H, Perna L, Weigl K, Mollers T, Schottker B, Thomsen H, et al.
Mol Psychiatry . 2021 Oct; 26(10):5823. PMID: 34599279
No abstract available.
3.
Prediction of clinical diagnosis of Alzheimer's disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years
Stocker H, Perna L, Weigl K, Mollers T, Schottker B, Thomsen H, et al.
Mol Psychiatry . 2020 May; 26(10):5812-5822. PMID: 32404947
The strongest genetic risk factor for Alzheimer's disease (AD) is the ε4 allele of Apolipoprotein E (APOE) and recent genome-wide association meta-analyses have confirmed additional associated genetic loci with smaller...
4.
Time trends in incidence and mortality of cutaneous melanoma in Germany
Garbe C, Keim U, Eigentler T, Amaral T, Katalinic A, Holleczek B, et al.
J Eur Acad Dermatol Venereol . 2018 Nov; 33(7):1272-1280. PMID: 30387899
Objectives: To characterize incidence and mortality trends of cutaneous melanoma (CM) in Germany to extrapolate these data until 2030. Methods: We evaluated data from the Centre for Cancer Registry Data...
5.
Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site
Jansen L, Buttmann-Schweiger N, Listl S, Ressing M, Holleczek B, Katalinic A, et al.
Oral Oncol . 2018 Jan; 76:8-15. PMID: 29290288
Introduction: The epidemiology of squamous cell oral cavity and pharyngeal cancers (OCPC) has changed rapidly during the last years, possibly due to an increase of human papilloma virus (HPV) positive...
6.
Implications from Under-reporting at Lifetime, Death Certificate Notifications and Trace-back on the Recorded Incidence of a "Newly" Established Population-based Cancer Registry
Holleczek B, Brenner H
Methods Inf Med . 2015 Dec; 55(2):182-92. PMID: 26678331
Objectives: Population-based cancer registries (CRs) are powerful tools for measuring cancer burden and progress against cancer. The study's objective was to investigate the effects of under-reporting at lifetime, death certificate...
7.
Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5
Anderson L, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin A, et al.
Eur J Cancer . 2015 Oct; 51(15):2144-2157. PMID: 26421818
Background: European regional variation in cancer survival was reported in the EUROCARE-4 study for patients diagnosed in 1995-1999. Relative survival (RS) estimates are here updated for patients diagnosed with cancer...
8.
[Rising incidence of papillary thyroid carcinoma in Germany]
Radespiel-Troger M, Batzler W, Holleczek B, Luttmann S, Pritzkuleit R, Stabenow R, et al.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz . 2013 Dec; 57(1):84-92. PMID: 24357177
Background: The incidence of thyroid cancer (TC), a rare malignancy, has strongly risen in recent decades. Possible causes of this rise include increasing diagnostic activity, nuclear tests after World War...
9.
Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements
Perna L, Schottker B, Holleczek B, Brenner H
J Clin Endocrinol Metab . 2013 Oct; 98(12):4908-15. PMID: 24106288
Context: Several studies suggested that low serum concentrations of 25-hydroxyvitamin D (25(OH)D) are associated with an increased risk of cardiovascular disease (CVD). However, the evidence is still inconclusive, mostly based...
10.
Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015
Arnold M, Holterhues C, Hollestein L, Coebergh J, Nijsten T, Pukkala E, et al.
J Eur Acad Dermatol Venereol . 2013 Aug; 28(9):1170-8. PMID: 23962170
Background: Melanoma is a significant health problem in Caucasian populations. The most recently available data from cancer registries often have a delay of several months up to a few years...